HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.

@article{Manos2009HRQLAM,
  title={HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.},
  author={Michael J. Manos and Thomas W. Frazier and Jeanne M. Landgraf and Margaret A. Weiss and Paul S. Hodgkins},
  journal={Current medical research and opinion},
  year={2009},
  volume={25 12},
  pages={3001-10}
}
OBJECTIVE To evaluate the impact of methylphenidate transdermal system (MTS) on health-related quality of life (HRQL) and medication satisfaction in children with attention-deficit/hyperactivity disorder (ADHD) as well as to identify potential moderators of HRQL and medication satisfaction. RESEARCH DESIGN AND METHODS Children aged 6-12 years diagnosed with ADHD were enrolled (N = 128) and 115 children completed the study. MTS dose was optimized over 5 weeks using 10-, 15-, 20-, or 30-mg… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Similar Papers

Loading similar papers…